Finally, this is a preliminary observational study to determine serum CEA and Cyfra21-1 as biomarkers for the diagnosis of LC risk in HRR groups; more longitudinal studies are needed to evaluate and validate the prognostic values in HRR groups with LC and to confirm these findings. Here, CEACAM5 is linked to laryngotracheoesophageal cleft.